This ad will auto close in 10 seconds

Supreme Court court seeks review of drug pricing policy

The Supreme Court has asked the central government to reexamine its pricing policy for essential medicines after a group of non-governmental organisations challenged the provisions, a lawyer involved in the case said.

Govt receives info on essential medicines from 400 drug makers

Government has received responses from around 400 drug manufacturers so far regarding data on essential medicines as part of efforts to decide their prices under the new drug pricing policy.

Government notifies new drug pricing policy

The government Thursday said the new drug policy which aims at bringing more medicines under price control has been notified.

Govt approves drug pricing policy to lower cost of medicines

The government on Thursday cleared the National Pharmaceutical Pricing Policy that will bring 348 essential drugs under price control, leading to reduction in prices.

GoM on drug pricing policy likely to meet next week

A panel of ministers, headed by Agriculture Minister Sharad Pawar, is expected to meet next week to fine tune the drug pricing policy after the Cabinet deferred taking a decision on it following objections from the Finance Ministry.

New policy should not make medicines costly: SC

Protecting the people's interest, the Supreme Court Thursday told the government that medicines should continue to be available at reasonable prices even after a decision on a new pricing policy is taken by November.

Decision on new drug pricing policy by mid-November

The court made it clear that the new NPPP (National Pharmaceutical Pricing Policy) which the government was bringing should not trigger any hike in the drug prices that are available in the market under the drug price control order.

DoP circulates draft Cabinet note on drug pricing policy

The department of pharmaceuticals (DoP) has circulated a draft Cabinet note for finalising the pharmaceutical pricing policy to fix rates of 348 essential medicines.

New drug policy to impact profitability of MNCs: ICRA

The proposed new drug pricing policy will impact profitability of pharmaceutical firms, mainly multi-national companies, in India while at the same time lead to a 10-15 percent reduction in prices of medicines, according to a report by credit rating agency ICRA.

New drug pricing policy may impact MNCs most: Analysts

The proposed draft pharma policy is likely to impact those multinational companies the most, which are in the premium pricing band, say analysts.

Drug pricing policy proposal in next two weeks: Pawar

Agriculture Minister Sharad Pawar, who is heading a GoM to formulate the drug pricing policy, on Thursday said the panel will finalise the proposal within the next two weeks.